April 26th 2024
Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis
View More
15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 11, 2024
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
HIV remission among children reported over 1 year after treatment interruption
March 7th 2024Research presented at the 2024 Conference on Retroviruses and Opportunistic Infections reveals that 4 children, treated with antiretroviral therapy within 48 hours of birth, have achieved over a year of HIV remission.
Read More
Evaluating GeneXpert point-of-care testing for STIs
March 6th 2024A recent study assessed the effectiveness of GeneXpert point-of-care testing in detecting chlamydia, gonorrhoea, and trichomonas, revealing promising results but highlighting concerns over sensitivity rates, particularly for trichomonas.
Read More
Dapivirine ring and oral PrEP found safe for preventing HIV in pregnant women
March 6th 2024Recent findings affirm the safety of monthly dapivirine vaginal rings and daily oral PrEP with tenofovir disoproxil fumarate and emtricitabine in preventing HIV transmission among pregnant cisgender women.
Read More
Study finds AI tool MySTIRisk effectively identifies high-risk STI subgroups
March 5th 2024A recent study revealed the effectiveness of the AI tool MySTIRisk in pinpointing high-risk subgroups for HIV and other sexually transmitted infections, shedding light on improved risk assessment and testing accessibility.
Read More
Enhancing ePN platforms for gonorrhea and chlamydia
February 28th 2024Recent study reveals the need for customizable electronic partner notification platforms for gonorrhea and chlamydia, highlighting the need for tailored solutions to improve sexually transmitted infection partner services.
Read More
CDC data reveals surge in maternal syphilis rates
February 16th 2024The Centers for Disease Control and Prevention's latest report unveils a 222% rise in maternal syphilis cases per 100,000 live births from 2016 to 2022, with increases observed across racial, age, and perinatal care groups nationwide.
Read More
Safely evaluating penicillin allergy with 2-step Graded Oral Challenge
February 14th 2024Recent findings revealed the efficacy and safety of the 2-step Graded Oral Challenge method in assessing penicillin allergy risk, offering a promising approach for improved patient care and antibiotic stewardship in low-risk individuals.
Read More
Decreased adolescent pregnancy and sexual health care during COVID-19 pandemic
February 13th 2024Adolescent pregnancy and sexual health care utilization declined during the COVID-19 pandemic, indicating significant disruptions in reproductive health services for young females, as highlighted in a recent study published in Pediatrics.
Read More
Innovating diagnosis and treatment for congenital syphilis
February 7th 2024Disparities in prenatal care and missed opportunities for diagnosis highlight the need for innovative approaches to tackle the rising prevalence of congenital syphilis, emphasizing standardized screening, higher quality diagnostics, and therapeutic interventions.
Read More
Study finds increased STI risk among transgender women with HIV
February 6th 2024A recent study found that transgender women with HIV face elevated risks of bacterial sexually transmitted infections, emphasizing the need for tailored interventions and further research to address the distinct challenges faced by this population.
Read More
Study shows increase in STIs in adolescents during the COVID-19 pandemic
February 2nd 2024Investigators recently noted that despite a decrease in adolescent hospital visits during the height of the pandemic, there was an increase in sexually transmitted infections (STIs) in this population group.
Read More
Early HPV vaccination in children
July 13th 2023Jonathan Miller, MD, pediatrician and chief of primary care, pediatrics at Nemours Children’s Health in the Delaware Valley, spoke about the latest data regarding early human papillomavirus (HPV) vaccination in children as young as 9 years old at the 2023 Pediatric Academic Societies meeting. He also provided some clinical pearls for opening the conversation with patients’ caretakers regarding earlier HPV vaccination.
Read More
New study explores racial disparity in HBV treatment initiation
April 11th 2023The cumulative probabilities of treatment initiation after meeting the criteria was not significantly different between the different racial groups and the incidence of major adverse liver outcomes was 0.1 per 100 person-years and did not differ by race.
Read More